These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 22094623)

  • 21. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
    J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
    Leigh R; Vethanayagam D; Yoshida M; Watson RM; Rerecich T; Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1212-7. PubMed ID: 12403690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of montelukast on bronchial hyperreactivity and lung function in asthmatic children aged 6-13 years.
    Visitsunthorn N; Chirdjirapong V; Santadilog S; Pajarn P; Jirapongsananuruk O; Komoltri C; Vichyanon P
    Asian Pac J Allergy Immunol; 2011 Jun; 29(2):127-33. PubMed ID: 21980827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a single dose of montelukast sodium on methacholine chloride PC20.
    Davis BE; Cockcroft DW
    Can Respir J; 2005; 12(1):26-8. PubMed ID: 15776131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophilic airway disorders associated with chronic cough.
    Niimi A; Matsumoto H; Mishima M
    Pulm Pharmacol Ther; 2009 Apr; 22(2):114-20. PubMed ID: 19121405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
    Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
    Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiology, diagnosis and treatment of cough variant asthma].
    Fujimura M
    Rinsho Byori; 2014 May; 62(5):464-70. PubMed ID: 25051661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
    Ciółkowski J; Mazurek H; Hydzik P; Stasiowska B
    Pulm Pharmacol Ther; 2016 Aug; 39():7-13. PubMed ID: 27234706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
    Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.
    Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG
    J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma.
    Dempsey OJ; Kennedy G; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jan; 109(1):68-74. PubMed ID: 11799368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small airway dysfunction in patients with cough variant asthma: a retrospective cohort study.
    Gao J; Wu H; Wu F
    BMC Pulm Med; 2021 Feb; 21(1):49. PubMed ID: 33536015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the management of asthma using leukotriene modifiers.
    Kemp JP
    Am J Respir Med; 2003; 2(2):139-56. PubMed ID: 14720013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.